Alemtuzumab induction therapy in HIV-positive renal transplant recipients

被引：6
|
作者：
Mclean, Florence E. [1 ]
Gathogo, Esther [2 ]
Goodall, Dawn [3 ]
Jones, Rachael [4 ]
Kinlcoh, Sabine [5 ]
Post, Frank A. [6 ]
机构：
[1] St George Hosp, Dept Renal Med, London, England
[2] Kings Coll London, Dept Renal Sci, London, England
[3] Hammersmith Hosp, Imperial Coll Kidney & Transplant Ctr, London, England
[4] Chelsea & Westminster Hosp, Dept HIV Med, London, England
[5] UCL, Div Infect & Immun, London, England
[6] Kings Coll Hosp NHS Fdn Trust, Dept HIV Res, London, England
来源：
AIDS | 2017年 / 31卷 / 07期
关键词：
KIDNEY-TRANSPLANTATION; EXPERIENCE; REJECTION;
D O I：
10.1097/QAD.0000000000001413
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1047 / 1048
页数：2
相关论文
共 50 条
  • [1] INFLAMMATORY AND REGULATORY CYTOKINE CHANGES IN HIV-POSITIVE TO HIV-POSITIVE RENAL TRANSPLANT RECIPIENTS
    Rautenbach, Stefanus Petrus
    Little, Francesca
    Marszalek, Marta
    Silva-Arrieta, Sandra
    Brander, Christian
    Gomez, Guadalupe
    Bofill, Marta
    Sanchez, Alex
    Muller, Elmi
    Gray, Clive M.
    [J]. HLA, 2017, 89 (06) : 394 - 395
  • [2] Basiliximab Induction in HIV-Positive Renal Transplant Recipients Compared to an HIV-Negative Cohort.
    Schulte, J.
    Richardson, C.
    Stosor, V.
    Cunningham, K.
    D'Agostino, C.
    Kane, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 679 - 680
  • [3] Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy
    Bosch, W.
    Poowanawittayakom, N.
    Chaikriangkrai, K.
    Mendez, J.
    Hellinger, W. C.
    Gonwa, T. A.
    Krishna, M.
    Pungpapong, S.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : E33 - E39
  • [4] Safety and efficacy of thymoglobulin in HIV-positive renal transplant recipients
    Carter, JT
    Melcher, ML
    Carlson, LL
    Roland, ME
    Freise, CE
    Hirose, R
    Stock, PG
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 547 - 547
  • [5] HIV-Positive Kidney Donor Selection for HIV-Positive Transplant Recipients
    Muller, Elmi
    Barday, Zunaid
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (04): : 1090 - 1095
  • [6] HIV-POSITIVE DONORS TO HIV-POSITIVE TRANSPLANT RECIPIENTS: THE ITALIAN EXPERIENCE
    Grossi, Paolo
    Dalla Gasperina, Daniela
    Morabito, Vincenzo
    Maria, Luisa Balsamo
    Carcano, Giulio
    Tozzi, Matteo
    Puoti, Massimo
    De Carlis, Luciano
    Codeluppi, Mauro
    Di Benedetto, Fabrizio
    Tavio, Marcello
    Ranghino, Andrea
    Viscoli, Claudio
    Costa, Alessandro Nanni
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 160 - 160
  • [7] Influence of Induction Therapy and Antiretroviral Regimen on Outcomes in HIV Positive Renal Transplant Recipients
    Marks, C. Rogers
    Durand, C.
    Hand, J.
    Abidi, M.
    Malinis, M.
    Barnaba, B.
    Patel, H.
    Alonso, C. D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 369 - 369
  • [8] Five Year Outcomes with Alemtuzumab Induction Therapy in Elderly Renal Transplant Recipients
    Casagrande, M.
    Cunningham, K.
    Tseng, C.
    D'Agostino, C.
    Wong, L.
    Richardson, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 354 - 355
  • [9] Transplantation: Alemtuzumab induction is safe for renal transplant recipients
    Myrvang H.
    [J]. Nature Reviews Nephrology, 2011, 7 (7) : 362 - 362
  • [10] Renal transplantation in HIV-positive recipients
    Locke J.E.
    Segev D.L.
    [J]. Current Infectious Disease Reports, 2010, 12 (1) : 71 - 75
12345